Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Utilize your credit card points for airfare to travel smarter and save. Explore the best ways to book your next flight!
17,662 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
MediaFuse launches TechnologyWire to broaden its distribution reach from crypto into the wider technology sector, lev...
This deep dive breaks down alto 2025 earnings, focusing on Q4 results, revenue growth, and what management signals fo...
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
U.S. labor data at month-end point to a cooling but stable job market, with initial claims around the low 200,000s an...
Broadcom inks a long-term extension with Apple through 2031, tying roughly 20% of AVGO's annual sales to the iPhone m...
Seven REITs cleared a strict financial screen, delivering dividends as high as 6.27% and drawing investor attention a...
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
Kroger's latest quarterly results sparked a sharp intraday move. Here’s a clear breakdown of the numbers, the drivers...
As AI stocks wobble after a rapid run, investors search for steadier footing. Here's this unstoppable vanguard could ...
When the world's wealthiest fund managers move, markets listen. This deep dive explains how the latest 13F season sho...
Chip-led gains lift the Nasdaq Composite as chipmakers regain leadership, while software names soften amid mixed dema...